Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
AOD-9604: Does not cause receptor burnout Does not require washout periods Does not lose effectiveness due to continuous use Consistency, not cycling, aligns with how it was designed to work
Feb 20, 2026 At the cellular level, AOD 9604 and tirzepatide trigger two completely separate cascades
This placebo controlled study in 24 elderly individuals showed that a single dose of an NAD+ booster before exercise improved fatigue index, physical recovery, and muscle function
Clinical Trials Multicenter, randomized controlled trial: To verify the efficacy and safety of AOD 9604 in humans
Some patients report it as a less painful alternative because the needle that goes into the fatty tissue just below the skin is thinner and shorter, usually one-half to five-eighths of an inch long
The short answer: it depends on how your provider gives it
